For the Inventor, By the Inventor

Enter assignee name

Scottsdale, AZ, United States of America

Medicis Pharmaceutical Corporation

USPTO Granted Patents = 71

% Expired Patents = 40.8

CIPO Patents = 11

EPO Patents = 7

Trademarks = 18

Forward Citations = 373

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Eugene H Gans (24 out of 27 patents)

Mitchell S Wortzman (22 out of 24 patents)

Michael T Nordsiek (17 out of 21 patents)

4. Bhiku G Patel (13 out of 19 patents)

5. Jefferson J Gregory (9 out of 9 patents)

6. Kuljit S Bhatia (9 out of 10 patents)

7. Kodumudi S Balaji (8 out of 12 patents)

8. Tze-Chiang Meng (7 out of 7 patents)

9. James H Lee (7 out of 9 patents)

10. R Todd Plott (7 out of 8 patents)

11. Sharon F Levy (6 out of 6 patents)

12. James H Kulp (6 out of 7 patents)

13. Valyn S Bahm (6 out of 6 patents)

14. Jason J Wu (6 out of 7 patents)

15. Robert Babilon (6 out of 6 patents)

Core Competencies:

Imiquimod Formulations

Actinic Keratosis

Dermatological Disorders

Corticosteroid Delivery

Lower Dosage Strength

Gastroretentive Dosage Forms

Acne Treatment

Photodynamic Therapy

Injectable Fillers

Skin Quality Improvement

Minocycline Dosage Forms

Pigmentation Disorders

71 patents: Sort by Forward Citations

1. 12692288 - Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same (2026-07-28),

2. 12642805 - USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES (2026-06-02),

3. 11850245 - Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts (2023-12-26),

4. 11318130 - 2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod (2022-05-03),

5. 11202752 - Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy (2021-12-21),

6. 10918635 - Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts (2021-02-16),

7. 10842802 - Controlled release pharmaceutical dosage forms (2020-11-24),

8. 10238645 - Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts (2019-03-26),

9. 10238644 - 2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod (2019-03-26),

10. 9980955 - Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts (2018-05-29),

11. 9642998 - Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream (2017-05-09),

12. 9561241 - Gastroretentive dosage forms for minocycline (2017-02-07),

13. 9492682 - Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis (2016-11-15),

14. 9370509 - 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod (2016-06-21),

15. 9271973 - Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy (2016-03-01),

Company Overview

Medicis Pharmaceutical Corporation, based in Scottsdale, AZ, specializes in the development and manufacturing of innovative dermatological formulations. The company focuses on addressing various skin conditions, including actinic keratosis and acne, through advanced technologies such as imiquimod formulations and corticosteroid delivery systems. Medicis is committed to enhancing patient outcomes with gastroretentive dosage forms and photodynamic therapy, positioning itself as a leader in the dermatology sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

71 Patents

#14 in Scottsdale, AZ

#60 in Arizona

#5,162 in US

#10,503 in the World

Scottsdale, AZ, United States of America

Medicis Pharmaceutical Corporation

Forward Citations = 373

78 inventors:

Eugene H Gans (24 out of 27 patents)

Mitchell S Wortzman (22 out of 24 patents)

Michael T Nordsiek (17 out of 21 patents)

4. Bhiku G Patel (13 out of 19 patents)

5. Jefferson J Gregory (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medicis Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/medicis-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…